We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Presence of Sleep Apnea Could Extend Life in the Elderly

By HospiMedica International staff writers
Posted on 06 Apr 2010
A new study has found that elderly patients with mild or moderate obstructive sleep apnea (OSA) showed significantly lower mortality than the general population.

Researchers at Heinrich Heine University (Düsseldorf, Germany) hypothesized that the intermittent phases of hypoxia in OSA syndrome (OSAS) might be accompanied by an increased coronary collateral vessel (CCV) development in patients with total coronary occlusion. More...
They then examined 34 patients with total coronary occlusions and classified them according to the apnea-hypopnea index (AHI), wherein an AHI value higher than 10 events per hour was classified as OSAS. CCVs were scored by visual analysis and were analyzed according to the Cohen and Rentrop grading system.

The researchers found that patients with OSAS had significantly more heart collaterals than patients without, even though there were no differences between the groups in age, gender, the presence of hypertension, smoking, or diabetes mellitus. There was no difference in left ventricular systolic function or left ventricular end-diastolic pressure. The study was published in the March 1, 2010, issue of Chest.

"If confirmed, these findings may have important clinical implications regarding treatment of the syndrome,” commented Professor Peretz Lavie, M.D., Ph.D., of the Technion – Israel Institute of Technology (Haifa, Israell) faculty of medicine, in an accompanying editorial. "Moreover, such findings – if combined with individual gene analysis – may provide new treatment strategies for cardiovascular protection.”

Sleep apnea patients have high blood levels of vascular endothelial growth factor (VEGF), a chemical signal produced by cells that stimulates the growth of new blood vessels to restore the oxygen supply to tissues when blood circulation is inadequate; it's production is triggered by a drop in blood oxygen levels. Over-expression of VEGF can cause vascular disease in the retina of the eye and other parts of the body, and can also contribute to cancer growth, as cancers that express VEGF are able to grow and metastasize.

Related Links:
Heinrich Heine University
Technion – Israel Institute of Technology


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.